$173 Million is the total value of SALEM CAPITAL MANAGEMENT INC's 67 reported holdings in Q2 2016. The portfolio turnover from Q1 2016 to Q2 2016 was 3.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JNJ | Sell | Johnson & Johnson | $8,829,000 | +8.6% | 72,785 | -3.2% | 5.09% | +11.3% |
| HON | Sell | Honeywell Int'l | $7,802,000 | +2.7% | 67,077 | -1.1% | 4.50% | +5.3% |
| WY | Sell | Weyerhaeuser Co. | $7,591,000 | -4.9% | 254,982 | -1.0% | 4.38% | -2.5% |
| UL | Sell | Unilever PLC ADR | $7,498,000 | +3.2% | 156,506 | -2.6% | 4.32% | +5.9% |
| CVS | Sell | CVS Health Corporation | $7,317,000 | -12.5% | 76,430 | -5.2% | 4.22% | -10.3% |
| GE | Sell | General Electric | $7,289,000 | -3.5% | 231,545 | -2.6% | 4.20% | -1.1% |
| PFE | Sell | Pfizer Inc. | $7,199,000 | +14.6% | 204,469 | -3.5% | 4.15% | +17.5% |
| MRK | Sell | Merck & Co. | $6,768,000 | +8.4% | 117,484 | -0.5% | 3.90% | +11.1% |
| DOW | Sell | Dow Chemical | $5,571,000 | -2.7% | 112,075 | -0.5% | 3.21% | -0.3% |
| INTC | Sell | Intel | $5,249,000 | +1.0% | 160,029 | -0.4% | 3.03% | +3.6% |
| BGGSQ | Sell | Briggs & Stratton | $3,719,000 | -12.8% | 175,575 | -1.6% | 2.14% | -10.6% |
| NSRGY | Sell | Nestle S A ADR | $3,528,000 | +0.5% | 45,637 | -3.0% | 2.03% | +3.1% |
| HAL | Sell | Halliburton Co. | $3,253,000 | +25.4% | 71,820 | -1.1% | 1.88% | +28.6% |
| DD | Sell | DuPont | $3,061,000 | -49.8% | 47,230 | -50.9% | 1.76% | -48.5% |
| MRO | Sell | Marathon Oil Corp. | $2,634,000 | +31.6% | 175,504 | -2.3% | 1.52% | +34.9% |
| NVS | Sell | Novartis AG ADR | $2,145,000 | -61.8% | 25,994 | -66.5% | 1.24% | -60.9% |
| COST | Sell | Costco Wholesale Corp. | $1,789,000 | -2.1% | 11,395 | -1.7% | 1.03% | +0.4% |
| MMM | Sell | 3M Company | $1,594,000 | +1.8% | 9,100 | -3.2% | 0.92% | +4.4% |
| XOM | Sell | Exxon Mobil | $1,442,000 | +7.2% | 15,385 | -4.4% | 0.83% | +9.9% |
| KMB | Sell | Kimberly-Clark | $1,230,000 | +1.1% | 8,950 | -1.1% | 0.71% | +3.7% |
| PAYX | Sell | Paychex Inc | $1,199,000 | +8.8% | 20,149 | -1.2% | 0.69% | +11.5% |
| CL | Sell | Colgate Palmolive | $1,094,000 | +2.2% | 14,950 | -1.3% | 0.63% | +4.8% |
| ABBV | Sell | AbbVie Inc. | $938,000 | -45.7% | 15,150 | -49.9% | 0.54% | -44.3% |
| GIS | Sell | General Mills | $670,000 | -3.0% | 9,400 | -13.8% | 0.39% | -0.5% |
| FDX | Sell | Fedex Corp. | $516,000 | -8.0% | 3,400 | -1.4% | 0.30% | -5.7% |
| UTX | Sell | United Technologies | $277,000 | -1.8% | 2,705 | -4.1% | 0.16% | +0.6% |
| STR | Sell | Questar Corp. | $273,000 | +1.1% | 10,750 | -1.4% | 0.16% | +3.3% |
| GSK | Sell | Glaxo Smithkline PLC-Spon ADR | $254,000 | -94.1% | 5,850 | -94.5% | 0.15% | -93.9% |
| CTAS | Sell | Cintas Corp | $245,000 | -8.9% | 2,500 | -16.7% | 0.14% | -6.6% |
| AAPL | Exit | Apple Computer | $0 | – | -2,075 | -100.0% | -0.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-07-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Microsoft | 38 | Q3 2022 | 8.6% |
| Honeywell Int'l | 38 | Q3 2022 | 5.5% |
| Merck & Co. | 38 | Q3 2022 | 5.6% |
| Weyerhaeuser Co. | 38 | Q3 2022 | 4.8% |
| Cisco Systems | 38 | Q3 2022 | 5.3% |
| Johnson & Johnson | 38 | Q3 2022 | 5.1% |
| Pfizer Inc. | 38 | Q3 2022 | 5.3% |
| International Paper | 38 | Q3 2022 | 4.6% |
| CVS Health Corporation | 38 | Q3 2022 | 5.6% |
| Verizon Communications | 38 | Q3 2022 | 3.1% |
View SALEM CAPITAL MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-11-29 |
| 13F-HR | 2022-07-27 |
| 13F-HR | 2022-04-07 |
| 13F-HR | 2022-01-18 |
| 13F-HR | 2021-10-12 |
| 13F-HR | 2021-07-13 |
| 13F-HR | 2021-04-15 |
| 13F-HR | 2021-01-12 |
| 13F-HR | 2020-10-13 |
| 13F-HR | 2020-07-20 |
View SALEM CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.